Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADORE: High-Dose DHA to Reduce Early Preterm Birth
NCT02626299Phase 3Completed
- Sponsor
- University of Kansas Medical Center
- Start
- Jun 2016
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of docosahexaenoic acid in preterm birth, sponsored by University of Kansas Medical Center. Started Jun 2016; status: completed.
02
Drugs
docosahexaenoic acid
03
Conditions
preterm birth
Beyond the preview
Go deeper on NCT02626299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02626299.